Schedule 13G ownership disclosure
IKENA ONCOLOGY INC
Common Stock, par value $0.001 per share · CUSIP: 45175G108
Event date: 2024-12-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BML Investment Partners, L.P.
Shares: 3,585,866 · Class: 7.4%
- Leonard Braden Michael
Shares: 3,645,866 · Class: 7.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-24-000124
- Form type
- SCHEDULE 13G
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Dec 31, 2024
- Reporting period
- Dec 23, 2024
- Description
- Schedule 13G beneficial ownership